{"product_id":"tirzepatide-ly3298176-sodium-p1206","title":"Tirzepatide (LY3298176) Sodium","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eTirzepatide (LY3298176, GIP\/GLP-1 RA, TZP) sodium is a dual GIP\/GLP-1 receptor agonist. The mapped target for this entry is Glucagon-like peptide-1 receptor; GIP receptor (GLP1R and GIPR). This target context is most often investigated as part of ligand-responsive signaling, where receptor occupancy can reshape downstream second-messenger output, trafficking, secretion, excitability, or transcriptional programs. In endocrine signaling studies, investigators commonly track ligand-responsive signaling, secretion, and endocrine feedback. In practical terms, this makes the product most relevant to experiments that need a defined and reversible way to perturb biology over short time scales.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eBecause it is described as a dual agonist, investigators often interpret responses in terms of coordinated signaling across more than one receptor axis and verify pathway balance with orthogonal readouts. In practice, dose-response design, timing, and matched control conditions are important for separating direct target engagement from delayed compensatory responses. Because more than one mapped molecular node is represented in the enrichment, pathway readouts should be interpreted with awareness that the phenotype may integrate multiple signaling inputs.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003epair peptide treatment with pathway-proximal signaling or trafficking readouts whenever possible\u003c\/li\u003e\n\u003cli\u003ecompare responses across cell states or model systems with different receptor abundance\u003c\/li\u003e\n\u003cli\u003edistinguish primary target engagement from downstream adaptation during longer incubations\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eExperimental interpretation should therefore connect early pathway changes with later phenotypic outputs, rather than relying on a single endpoint in isolation.\u003c\/p\u003e\u003ch2\u003eFormat Considerations\u003c\/h2\u003e\u003cp\u003eFor routine mechanistic work, the unmodified catalog format provides a consistent starting point for concentration-response studies, benchmark experiments, and orthogonal validation. In comparative workflows, keeping the listed sodium format constant across comparator groups can reduce avoidable formulation-related differences. This is particularly helpful for comparative experiments, benchmark studies, and orthogonal validation in which small differences in formulation or handling can complicate interpretation. For peptide-centered workflows, conclusions are usually strongest when biological readouts are paired with consistent preparation and appropriately matched reference conditions.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"1 mg","offer_id":57636823564633,"sku":"P1206-1MG","price":291.0,"currency_code":"EUR","in_stock":true},{"title":"5 mg","offer_id":57636823597401,"sku":"P1206-5MG","price":783.0,"currency_code":"EUR","in_stock":true},{"title":"25 mg","offer_id":57636823630169,"sku":"P1206-25MG","price":1942.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/p1206-tirzepatide-chemical-structure.gif?v=1774212410","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/tirzepatide-ly3298176-sodium-p1206","provider":"Absource Diagnostics","version":"1.0","type":"link"}